Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04583930
What this trial is testing

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

Who this might be right for
Hemophilia A
Prof. Dr. Dr. Thomas Hilberg 48
Not applicableStudy completedNCT02922231
What this trial is testing

Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Large-scale testing (Phase 3)Study completedNCT01311648
What this trial is testing

BAY81-8973 Pediatric Safety and Efficacy Trial

Who this might be right for
Haemophilia A
Bayer 94
Testing effectiveness (Phase 2)Study completedNCT00005797
What this trial is testing

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 125
Large-scale testing (Phase 3)Study completedNCT00093210
What this trial is testing

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02634918
What this trial is testing

Ultrasonography in Hemophilic Joint Disease and Serum Markers

Who this might be right for
Hemophilia AHemophilia BHemarthroses
Northwell Health 30
Not applicableStudy completedNCT04560933
What this trial is testing

Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 186
Large-scale testing (Phase 3)Study completedNCT00945906
What this trial is testing

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Who this might be right for
Factor XIII Deficiency
CSL Behring 61
Large-scale testing (Phase 3)Study completedNCT02263456
What this trial is testing

Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B

Who this might be right for
Haemophilia B
Bio Products Laboratory
Large-scale testing (Phase 3)Active Not RecruitingNCT05662319
What this trial is testing

Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

Who this might be right for
Hemophilia
Sanofi 91
Not applicableWithdrawnNCT06634836
What this trial is testing

Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B

Who this might be right for
Hemophilia AHemophilia B
Pfizer
Not applicableStudy completedNCT01000844
What this trial is testing

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Who this might be right for
Hemophilia
University of Colorado, Denver 11
Early research (Phase 1)Ended earlyNCT01191372
What this trial is testing

First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

Who this might be right for
Hemophilia
Baxalta now part of Shire 17
Not applicableLooking for participantsNCT07096349
What this trial is testing

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Investigación en Hemofilia y Fisioterapia 109
Testing effectiveness (Phase 2)Looking for participantsNCT07575308
What this trial is testing

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB

Who this might be right for
Von Willebrand Disease (VWD)Heavy Menstrual Bleeding (HMB)
Alnylam Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT02234323
What this trial is testing

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 108
Not applicableLooking for participantsNCT03773159
What this trial is testing

Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

Who this might be right for
Von Willebrand DiseasesMajor Constitutional ThrombopathyPatient on Antiplatelet Drugs
Centre Hospitalier Universitaire Dijon 200
Not applicableEnded earlyNCT00995046
What this trial is testing

Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Hospices Civils de Lyon 5
Testing effectiveness (Phase 2)Study completedNCT00001596
What this trial is testing

Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

Who this might be right for
AlbinismInborn Errors of MetabolismOculocutaneous Albinism+2 more
William Gahl, M.D. 35
Testing effectiveness (Phase 2)Ended earlyNCT00623727
What this trial is testing

BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 143
Next Page